Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-07-15

FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Supplemental Application (Xeris Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for GVOKE HYPOPEN 0.5 mg auto-injector (glucagon injection, solution) by Xeris Pharmaceuticals, updating labeling for th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR (GLUCAGON INJECTION, SOLUTION)

Snippet

SUPPL AP for GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR (GLUCAGON INJECTION, SOLUTION)